| Dipa Patolia, | |
|
2040 Camfield Ave, Commerce, CA 90040-1502 | |
| (877) 462-2582 | |
| Not Available |
| Full Name | Dipa Patolia |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2040 Camfield Ave, Commerce, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245754399 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 70496 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dipa Patolia, 2040 Camfield Ave, Los Angeles, CA 90040 Ph: () - | Dipa Patolia, 2040 Camfield Ave, Commerce, CA 90040-1502 Ph: (877) 462-2582 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the National Institutes of Health ("NIH") has awarded Dr. Jacek Pinski, Associate Professor of Medicine at the Norris Comprehensive Cancer Center of the University of Southern California, a grant of about US$1.5 million over three years to conduct a Phase 1/2 study in refractory prostate cancer with the Company's doxorubicin LHRH receptor targeted conjugate compound, AEZS-108.
The Centre for Development Cooperation (CCD) and several research groups of the Universitat Politècnica de Catalunya (UPC) are working together with the World Health Organization (WHO) to develop a global database on the situation and evolution of Chagas disease.
Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also found that higher doses of the drugs were associated with lower risk of recurrence.
For the first time, researchers have shown that a chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) is as safe and effective as infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) in the first-line treatment of metastatic colorectal carcinoma (MCRC).
In a national online survey conducted by the American Society of Registered Nurses, 41% of the 781 Registered Nurses surveyed on April 28 reported that generic drugs are less effective than their equivalent brand-name counterparts.
› Verified 7 days ago
Dr. Trinh X. Tran, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5600 Whittier Blvd, Commerce, CA 90022 Phone: 323-725-7861 Fax: 323-725-7861 | |
Carol Rim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3302 Garfield Ave, Commerce, CA 90040 Phone: 800-511-5144 | |
Jae Suh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5724 E Olympic Blvd, Commerce, CA 90022 Phone: 323-722-1515 Fax: 323-722-2083 | |
Felicita Mojica-olson, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3302 Garfield Ave, Commerce, CA 90040 Phone: 800-541-5144 Fax: 323-832-9890 | |
Walter Valdes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5600 Whittier Blvd, T-0189, Commerce, CA 90022 Phone: 323-725-7861 | |
Julie Ngo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 Camfield Ave, Commerce, CA 90040 Phone: 877-462-2582 |